Selectis Health (GBCS) Depreciation & Amortization (CF) (2010 - 2025)

Selectis Health has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $364699.0 for Q3 2025.

• Depreciation & Amortization (CF) for Q3 2025 came in at $364699.0, down 2.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (down 30.54% YoY), and the FY2025 annual result was $1.5 million, down 6.09% from the prior year.
• Depreciation & Amortization (CF) came in at $364699.0 for Q3 2025 at Selectis Health, up from $362742.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $453608.0 in Q3 2022 to a low of $357868.0 in Q3 2023.
• The 5-year median for Depreciation & Amortization (CF) is $430754.0 (2023), against an average of $413306.3.
• Across the five-year window, Depreciation & Amortization (CF) advanced 18.21% in 2021 and decreased 21.11% in 2023, its largest moves.
• Selectis Health's Depreciation & Amortization (CF) stood at $447070.0 in 2021, then dropped by 0.64% to $444195.0 in 2022, then decreased by 3.03% to $430754.0 in 2023, then slipped by 15.79% to $362723.0 in 2024, then climbed by 0.54% to $364699.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $364699.0 (Q3 2025), $362742.0 (Q2 2025), and $363020.0 (Q1 2025), per Business Quant data.